Application of Bushen Xiezhuo Prescription combined with Irbesartan Tablets on Cys-C and Hcy in patients with early diabetic nephropathy and study on its mechanism
ZONG Hai-tao LI Jin-hua LI Ya-ning
Department of Nephrology,Jiujiang Hospital of Traditional Chinese Medicine,Jiangxi Province,Jiujiang 332000,China
Abstract：Objective To investigate the effect of Bushen Xiezhuo Prescription combined with Irbesartan Tablets in the treatment of early diabetic nephropathy and its influence on serum cystatin C (Cys C)and serum homocysteine(Hcy).Methods From January 2020 to January 2021,80 patients with early diabetic nephropathy treated in Department of Nephropathy of Jiujiang Hospital of Traditional Chinese Medicine in Jiangxi Province were selected and divided into the treatment group 1 and the treatment group 2 according to random number table method,40 cases in each group.A total of 10 healthy persons who took physical examination in Physical Examination Center of Jiujiang Hospital of Traditional Chinese Medicine in Jiangxi Province in the same period were selected as the control group.The treatment group 2 and the treatment group 1 were given intensive hypoglycemic treatment,diet therapy,exercise therapy,nutrition therapy and other basic treatment.The treatment group 1 was treated with Irbesartan Tablets on the basis of the basic treatment,and the treatment group 2 was treated with Bushen Xiezhuo Prescription on the basis of the treatment group 1.The levels of Cys C and Hcy of the three groups were observed,the symptom scores and related laboratory indexes of the treatment group 2 and the treatment group 1 before treatment and after three courses of treatment were recorded,and the traditional Chinese medicine symptom efficacy,clinical efficacy and the total incidence of adverse reactions of the treatment group 2 and the treatment group 1 were compared.Results There were significant differences in the levels of Cys C and Hcy among the three groups before treatment(P＜0.05).The levels of Cys C and Hcy in the treatment group 2 and the treatment group 1 were higher than those in the control group,and the differences were statistically significant(P＜0.05).There were no significant differences in the levels of Cys C and Hcy between the two groups before treatment(P＞0.05).The symptom scores of the treatment group 2 and the treatment group 1 after treatment were lower than those before treatment,the differences were statistically significant(P＜0.05).The symptom score of the treatment group 2 after treatment was lower than that of the treatment group 1,the difference was statistically significant(P＜0.05).The levels of Cys C,Hcy,microalbuminuria,D-dimer,fasting blood glucose,triglyceride,total cholesterol,serum creatinine(SCr),blood urea nitrogen(BUN),uric acid and C-reactive protein (CRP)in the treatment group 2 and the treatment group 1 after treatment were lower than those before treatment,and the differences were statistically significant(P＜0.05).The levels of Cys C,Hcy,microalbuminuria,D-dimer,fasting blood glucose,triglyceride,total cholesterol,SCr,BUN,uric acid and CRP in the treatment group 2 after treatment were lower than those in the treatment group 1,and the differences were statistically significant(P＜0.05).The total effective rate of traditional Chinese medicine syndrome in treatment group 2 was 92.50%,which was higher than that in treatment group 1(72.50%),and the difference was statistically significant(P＜0.05).The total effective rate of the treatment group 2 was 95.00%,which was higher than 72.50% of the treatment group 1,the difference was statistically significant(P＜0.05).There was no significant difference in the total incidence of adverse reactions between the treatment group 2 and the treatment group 1 (P＞0.05).Conclusion The combination of Bushen Xiezhuo Prescription and Irbesartan Tablets has a good therapeutic effect on patients with early diabetic nephropathy,that is,it improves the clinical efficacy and does not increase adverse reactions.It provides a new way of thinking for the treatment of early diabetic nephropathy with traditional Chinese and Western medicine.
宗海涛；李金花；李亚宁. 补肾泄浊方联合厄贝沙坦片对早期糖尿病肾病患者C ys-C、H cy的影响及机制研究[J]. 中国当代医药, 2021, 28(31): 14-18.
ZONG Hai-tao；LI Jin-hua；LI Ya-ning. Application of Bushen Xiezhuo Prescription combined with Irbesartan Tablets on Cys-C and Hcy in patients with early diabetic nephropathy and study on its mechanism. 中国当代医药, 2021, 28(31): 14-18.
京公网安备 11010502046607号